CD8A and neoplasm: Expanded Vδ2− cells retaining expression of PD-1, 4-1BB and TIM3 (Extended Data Fig. 7) were able to kill autologous tumor cells at comparable levels and kinetics to αβ CD8+ T cells (Fig. 3d).